Viral cardiomyopathy

From Wikipedia, the free encyclopedia
Viral cardiomyopathy
SpecialtyCardiology

Viral cardiomyopathy occurs when viral infections cause myocarditis with a resulting thickening of the myocardium and dilation of the ventricles. These viruses include Coxsackie B and adenovirus, echoviruses, influenza H1N1, Epstein-Barr virus, rubella (German measles virus), varicella (chickenpox virus), mumps, measles, parvoviruses, yellow fever, dengue fever, polio, rabies and the viruses that cause hepatitis A and C,[1][2][3] as well as COVID-19,[4][5] which has been seen to cause this in persons otherwise thought to have a "low risk" of the virus's effects.[6]

In the case of COVID-19, not only can myocarditis arise from it, but it has also been observed to occur in rare cases following immunization against it.[7] In July 2021, the European Medicines Agency's safety committee recommended[8] that myocarditis and pericarditis be added as side effects of the Pfizer vaccine and Moderna vaccine, and in October 2021, a few countries have limited or halted the use of the latter as a prevention.[9][10]

See also[]

References[]

  1. ^ Barbandi M, Cordero-Reyes A, Orrego CM, Torre-Amione G, Seethamraju H (Jan 2012). "A case series of reversible acute cardiomyopathy associated with H1N1 influenza infection". Methodist DeBakey Cardiovascular Journal. 8 (1): 42–5. doi:10.14797/mdcj-8-1-42. PMC 3405785. PMID 22891110.
  2. ^ Badorff C; Lee G. H.; Knowlton K. U. (2000). "Enteroviral cardiomyopathy: bad news for the dystrophin-glycoprotein complex". Herz. 25 (3): 227–32. doi:10.1007/s000590050011. PMID 10904843. S2CID 25973717.
  3. ^ Mutlu H, Alam M, Ozbilgin OF (2011). "A rare case of Epstein-Barr virus-induced dilated cardiomyopathy". Heart Lung. 40 (1): 81–7. doi:10.1016/j.hrtlng.2009.12.012. PMID 20561866.
  4. ^ Rathore, Sawai Singh; Rojas, Gianpier Alonzo; Sondhi, Manush; Pothuru, Suveenkrishna; Pydi, Reshma; Kancherla, Neeraj; Singh, Romil; Ahmed, Noman Khurshid; Shah, Jill; Tousif, Sohaib; Baloch, Unaiza Tariq (2021). "Myocarditis associated with Covid-19 disease: A systematic review of published case reports and case series". International Journal of Clinical Practice. 75 (11): e14470. doi:10.1111/ijcp.14470. ISSN 1742-1241. PMID 34235815. S2CID 235768792.
  5. ^ Siripanthong, Bhurint; Nazarian, Saman; Muser, Daniele; Deo, Rajat; Santangeli, Pasquale; Khanji, Mohammed Y.; Cooper, Leslie T.; Chahal, C. Anwar A. (September 2020). "Recognizing COVID-19–related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management". Heart Rhythm. 17 (9): 1463–1471. doi:10.1016/j.hrthm.2020.05.001. ISSN 1547-5271. PMC 7199677. PMID 32387246.
  6. ^ Siripanthong B, Nazarian S, Muser D, Deo R, Santangeli P, Khanji M, Cooper L, Jr, Chahal A (5 May 2020). "Recognizing COVID-19–related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management". Heart Rhythm. 17 (9): 1463–1471. doi:10.1016/j.hrthm.2020.05.001. PMC 7199677. PMID 32387246.
  7. ^ Montgomery J, Ryan M, Engler R, et al. (29 June 2021). "Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military". JAMA Cardiol. 6 (10): 1202–1206. doi:10.1001/jamacardio.2021.2833. PMC 8243257. PMID 34185045.
  8. ^ "Comirnaty and Spikevax: possible link to very rare cases of myocarditis and pericarditis". European Medicines Agency. 9 July 2021.
  9. ^ "Iceland Joins Nordic Peers in Halting Moderna Covid Vaccinations". Bloomberg.com. 2021-10-08. Archived from the original on 2021-10-08. Retrieved 2021-10-12.
  10. ^ Lehto, Essi (2021-10-07). "Finland joins Sweden and Denmark in limiting Moderna COVID-19 vaccine". Reuters. Archived from the original on 2021-11-08. Retrieved 2021-10-12.

External links[]

Retrieved from ""